Vicarious Surgical Inc. (RBOT) Revenue History
Annual and quarterly revenue from 2019 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
RBOT Revenue Growth
RBOT Revenue Analysis (2019–2025)
As of May 8, 2026, Vicarious Surgical Inc. (RBOT) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q1 2026) recorded $0 in revenue.
Looking at the longer-term picture, RBOT's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including ISRG (+21.4% YoY), MASI (-14.4% YoY), and SSYS (-3.7% YoY). Compare RBOT vs ISRG →
RBOT Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| RBOTCurrent | $0 | - | - | - | |
 ISRG | $10.1B | +21.4% | +18.2% | 29.3% | |
 MASI | $1.5B | -14.4% | +5.9% | 20.5% | |
 SSYS | $551M | -3.7% | +1.1% | -10.7% | |
 TMCI | $213M | +1.6% | +30.0% | -25.5% | |
 SYK | $25.1B | +11.2% | +11.8% | 19.5% |
RBOT Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $-1,425,000 | - | $-50,968,000 | - |
| 2024 | $0 | - | $-2,107,000 | - | $-66,555,000 | - |
| 2023 | $0 | - | $-1,854,000 | - | $-80,666,000 | - |
| 2022 | $0 | - | $0 | - | $-80,078,000 | - |
| 2021 | $0 | - | $0 | - | $-38,223,000 | - |
| 2020 | $0 | - | $0 | - | $-12,985,000 | - |
| 2019 | $0 | - | $0 | - | $-9,783,000 | - |
See RBOT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RBOT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare RBOT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonRBOT — Frequently Asked Questions
Quick answers to the most common questions about buying RBOT stock.
Is RBOT's revenue growth accelerating or slowing?
RBOT TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is RBOT's long-term revenue growth rate?
Vicarious Surgical Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is RBOT's revenue distributed by segment?
RBOT reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2025 are available for download. Segment mix reveals concentration and diversification trends.